Animal models support a predominant gain‐of‐function mechanism for C9orf72 pathogenesis, but the role of DPR proteins in disease initiation and progression in human ALS and FTD patients remains unresolved. The gene discussed is C9orf72; the disease is frontotemporal dementia.